Amneal Pharmaceuticals (AMRX) Revenue (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Revenue of $722.5 million for Q1 2026, up 3.9% year-over-year from $695.4 million in Q1 2025, and down 11.27% quarter-over-quarter from $814.3 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Revenue (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Revenue history runs 10 years deep, the most recent figure standing at $722.5 million for Q1 2026.
- In Q1 2026, Revenue rose 3.9% year-over-year to $722.5 million; the TTM figure through Mar 2026 stood at $3.0 billion (up 7.62% YoY), while the FY2025 annual figure was $3.0 billion, up 8.05% from the prior year.
- Revenue for Q1 2026 stood at $722.5 million, down from $814.3 million in the prior quarter.
- The five-year high for Revenue was $814.3 million in Q4 2025, with the low at -$1.6 billion in Q4 2022.
- The 5-year median for Revenue is $659.2 million (2024), against an average of $526.4 million.
- The sharpest annual moves came in 2022 and 2023: Revenue plunged 394.8% in 2022, then jumped 138.98% in 2023.
- Amneal Pharmaceuticals' Revenue stood at -$1.6 billion in 2022, then jumped by 138.98% to $617.0 million in 2023, then gained by 18.4% to $730.5 million in 2024, then increased by 11.47% to $814.3 million in 2025, then retreated by 11.27% to $722.5 million in 2026.
- Business Quant data shows AMRX's Revenue at $722.5 million in Q1 2026, $814.3 million in Q4 2025, and $784.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | 796.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 796.20 Mn |
| Mar 31, 2026 | 722.52 Mn |
| Dec 31, 2025 | 814.32 Mn |
| Sep 30, 2025 | 784.51 Mn |
| Jun 30, 2025 | 724.51 Mn |
| Mar 31, 2025 | 695.42 Mn |
| Dec 31, 2024 | 730.52 Mn |
| Sep 30, 2024 | 702.47 Mn |
| Jun 30, 2024 | 701.78 Mn |
| Mar 31, 2024 | 659.19 Mn |
| Dec 31, 2023 | 616.98 Mn |
| Sep 30, 2023 | 620.04 Mn |
| Jun 30, 2023 | 599.05 Mn |
| Mar 31, 2023 | 557.54 Mn |
| Dec 31, 2022 | -1.58 Bn |
| Sep 30, 2022 | 545.56 Mn |
| Jun 30, 2022 | 559.36 Mn |
| Mar 31, 2022 | 497.63 Mn |
| Dec 31, 2021 | 536.90 Mn |
| Sep 30, 2021 | 528.59 Mn |